Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M24.4Revenue (TTM) $M18.2Net Margin (%)-47.1Altman Z-Score-6.4
Enterprise Value $M-13.3EPS (TTM) $-0.9Operating Margin %-48.5Piotroski F-Score6
P/E(ttm)--Beneish M-Score-2.8Pre-tax Margin (%)-47.1Higher ROA y-yY
Price/Book0.510-y EBITDA Growth Rate %-20.4Quick Ratio11.9Cash flow > EarningsY
Price/Sales1.15-y EBITDA Growth Rate %-14.6Current Ratio11.9Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-17.2Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-18.9Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M11.1ROIC % (ttm)-96.1Gross Margin Increase y-yY

Gurus Latest Trades with VICL

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VICLJohn Rogers 2016-09-30 Add$3 - $4.54
($4.01)
$ 2.21-45%Add 0.17%529,913
VICLJohn Rogers 2016-06-30 Reduce$3.61 - $4.72
($4.08)
$ 2.21-46%Reduce -4.48%528,991
VICLJohn Rogers 2016-03-31 Reduce-0.01%$3.05 - $4.53
($3.66)
$ 2.21-40%Reduce -20.34%553,776
VICLJohn Rogers 2015-12-31 Reduce$3.5 - $5.34
($4.14)
$ 2.21-47%Reduce -6.51%695,218
VICLJohn Rogers 2015-09-30 Reduce$4.58 - $7
($6.13)
$ 2.21-64%Reduce -0.32%743,627
VICLJohn Rogers 2015-06-30 Add$7 - $14.8
($9.95)
$ 2.21-78%Add 7.21%746,052
VICLJohn Rogers 2015-03-31 Add$8.55 - $11.7
($10.16)
$ 2.21-78%Add 7.34%695,895
VICLJohn Rogers 2014-12-31 Add0.01%$10 - $12.5
($11.23)
$ 2.21-80%Add 10.25%648,322
VICLGeorge Soros 2014-09-30 Sold Out $11.2 - $13.1
($12.34)
$ 2.21-82%Sold Out0
VICLJohn Rogers 2014-09-30 Add$11.2 - $13.1
($12.34)
$ 2.21-82%Add 1.48%588,071
VICLGeorge Soros 2014-06-30 Buy $11.2 - $13.5
($11.96)
$ 2.21-82%New holding5,818
VICLJohn Rogers 2014-03-31 Reduce-0.02%$11.9 - $17.2
($14.17)
$ 2.21-84%Reduce -17.94%579,509
VICLJohn Rogers 2013-12-31 Add0.03%$10.15 - $14.9
($12.01)
$ 2.21-82%Add 39.31%706,210
VICLJohn Rogers 2013-09-30 Reduce$11.9 - $42.6
($23.82)
$ 2.21-91%Reduce -1.28%506,924
VICLJohn Rogers 2013-06-30 Add0.13%$29.3 - $42.2
($35.16)
$ 2.21-94%Add 93.26%513,482
VICLJohn Rogers 2013-03-31 Add0.08%$30.8 - $42.6
($35.55)
$ 2.21-94%Add 71.60%265,697
VICLJohn Rogers 2012-12-31 Add0.03%$27.4 - $43.2
($33.03)
$ 2.21-93%Add 49.50%154,836
VICLJohn Rogers 2012-09-30 Add0.01%$33 - $45.8
($36.95)
$ 2.21-94%Add 8.77%103,566
VICLJohn Rogers 2012-06-30 Add0.01%$28 - $36
($30.66)
$ 2.21-93%Add 8.55%95,219
VICLJohn Rogers 2012-03-31 Add0.01%$30.2 - $44.9
($34.52)
$ 2.21-94%Add 26.34%87,719
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VICL is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


VICL: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SMITH LAWRENCE RUSSELLVP, Vaccine Research 2017-01-11Sell54$2.48-10.89view
SAMANT VIJAY BPresident & CEO 2017-01-10Sell5,763$2.45-9.8view
MERTON ROBERT CDirector 2016-12-22Sell4,000$2.24-1.34view
MERTON ROBERT CDirector 2016-12-20Sell4,327$2.210view
SAMANT VIJAY BPresident & CEO 2016-12-13Sell15,699$2.39-7.53view
DOUGLAS R GORDONDirector 2016-12-12Sell10,078$2.39-7.53view
LYONS GARY ADirector 2016-12-05Sell7,078$2.3-3.91view
SMITH LAWRENCE RUSSELLVP, Vaccine Research 2016-10-11Sell54$3.05-27.54view
SMITH LAWRENCE RUSSELLVP, Vaccine Research 2016-07-11Sell54$4.46-50.45view
MERTON ROBERT CDirector 2016-06-14Buy9,000$4.34-49.08view

Quarterly/Annual Reports about VICL:

News about VICL:

Articles On GuruFocus.com
CEOs Sell Vical, PhotoMedex, E.W. Scripps, Smart & Final Stores Jan 18 2016 
Red Hat (RHT) and Five Below (FIVE) Strong Performance Metrics; Vical (VICL) Targets Multi-billion S Mar 26 2015 
John Rogers Comments on Vical Feb 26 2014 
Kids Decide on Dolls or Devices - JAKK, Others 70% Off Sep 17 2013 
Weekly CFO Buys Highlight: VICL, EXA, UCBA, YORW, MGI Jan 21 2013 
Vical Inc. Insiders Boost Shares after Company’s NASDAQ Listing Gets Upgrade Jan 17 2013 
Two Biotech Stocks to Buy, One to Avoid Jan 09 2012 
Vical Inc. (VICL) CEO Vijay B Samant buys 1,000 Shares Jan 20 2011 
Vical Inc. Reports Operating Results (10-Q) Aug 06 2010 
Vical Inc. Reports Operating Results (10-Q) May 07 2010 

More From Other Websites
ETFs with exposure to Vical, Inc. : January 6, 2017 Jan 06 2017
ETFs with exposure to Vical, Inc. : December 13, 2016 Dec 13 2016
VICAL INC Financials Nov 15 2016
ETF’s with exposure to Vical, Inc. : November 7, 2016 Nov 07 2016
VICAL INC Files SEC form 10-Q, Quarterly Report Nov 04 2016
Vical, Inc. :VICL-US: Earnings Analysis: Q3, 2016 By the Numbers : November 4, 2016 Nov 04 2016
Q3 2016 Vical Inc Earnings Release - Before Market Open Nov 03 2016
Vical Reports Third Quarter 2016 Financial Results Nov 03 2016
VICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Nov 03 2016
Vical Reports Third Quarter 2016 Financial Results Nov 03 2016
Investor Calendar Invites You to the Vical Third Quarter 2016 Earnings Webcast Live on Thursday,... Nov 02 2016
Vical Announces News Release and Conference Call Schedule for Third Quarter 2016 Financial Results Oct 27 2016
Vical Announces News Release and Conference Call Schedule for Third Quarter 2016 Financial Results Oct 27 2016
ETF’s with exposure to Vical, Inc. : October 25, 2016 Oct 25 2016
VICAL INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and... Oct 17 2016
Vical Announces Initiation of a Phase 2 Trial of Its HSV-2 Therapeutic DNA Vaccine for Genital... Sep 26 2016
Vical Slumps, Cytomegalovirus Vaccine Fails in Phase II Study Sep 20 2016
Vical and Astellas Announce Topline Results from a Phase 2 Study of Investigational Cytomegalovirus... Sep 19 2016
Sarepta Therapeutics Inc (SRPT), PTC Therapeutics, Inc. (PTCT) and More: Here’s Why These Stocks... Sep 19 2016
ETF’s with exposure to Vical, Inc. : September 19, 2016 Sep 19 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)